# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k093700   
B. Purpose for Submission: New Device   
C. Measurand: Calibration verification and assay range verification material for hCG   
D. Type of Test: Not applicable   
E. Applicant: Roche Diagnostics   
F. Proprietary and Established Names: Elecys HCG STAT CalCheck 5   
G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>JJX</td><td rowspan=1 colspan=1>Class I, reserved</td><td rowspan=1 colspan=1>21CFR§862.1660</td><td rowspan=1 colspan=1>Clinical Chemistry</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for use below.

2. Indication(s) for use:

The Elecsys HCG STAT CalCheck 5 is an assayed control for use in calibration verification and for use in the verification of the assay range established by the Elecsys

HCG STAT reagent on the indicated Elecys and cobas e immunoassay analyzers.

3. Special conditions for use statement(s):

The Elecsys HCG STAT CalCheck 5 is not intended to be used as a primary calibrator or routine control material.

4. Special instrument requirements:

The labeling states that the CalChecks are for use with the Elecsys HCG STAT reagent kit on the Elecys 2010, cobas e411 and cobas e601 test systems.

# I. Device Description:

The Elecys HCG STAT CalCheck 5 is a lyophilized product consisting of HCG in human serum matrix. During manufacture, the analyte is spiked into the matrix at the target concentrations listed below. Cal Check Level 1 contains no analyte.

<table><tr><td rowspan=1 colspan=1>Elecys HCG Stat CalCheck 5Level</td><td rowspan=1 colspan=1>Target ValuemlU/mL</td></tr><tr><td rowspan=1 colspan=1>Check 1</td><td rowspan=1 colspan=1>&lt; 0.500</td></tr><tr><td rowspan=1 colspan=1>Check 2</td><td rowspan=1 colspan=1>3.85</td></tr><tr><td rowspan=1 colspan=1>Check 3</td><td rowspan=1 colspan=1>4310</td></tr><tr><td rowspan=1 colspan=1>Check 4</td><td rowspan=1 colspan=1>6750</td></tr><tr><td rowspan=1 colspan=1>Check 5</td><td rowspan=1 colspan=1>8400</td></tr></table>

The human source materials were prepared exclusively from the blood of donors tested individually and shown to be free from HBsAg and antibodies to HCV and HIV. The testing methods applied were FDA-approved or cleared in compliance with the European Directive 98/70/EC, Annex II, List A.

# J. Substantial Equivalence Information:

1. Predicate device name(s) Elecys $\mathrm { H C G + } \beta$ CalCheck 5

2. Predicate K number(s) k092168

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecys HCG STAT CalCheck 5(Candidate Device)</td><td rowspan=1 colspan=1>Elecys HCG+β CalCheck(k092168)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Calibration VerificationMaterial</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Reconstitute Check 1, Check2, Check 3, Check 4, andCheck 5 with exactly 1.0 mLdistilled or deionized water.Allow to stand closed for 15minutes, mix gently byinversion.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened: store at 2-8°C untilexpiration date. Reconstituted:20-25°C: 4 hours</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum matrix</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Five</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecys HCG STAT CalCheck 5(Candidate Device)</td><td rowspan=1 colspan=1>Elecys HCG+β CalCheck(k092168)</td></tr><tr><td rowspan=1 colspan=1>Reagent</td><td rowspan=1 colspan=1>The Elecsys HCG STATCalCheck 5 is an assayedcontrol for use in calibrationverification and for use in theverification of the assay rangeestablished by the ElecysHCG STAT reagent on theindicated Elecys and cobas eimmunoassay analyzers.</td><td rowspan=1 colspan=1>The Elecys HCG+β CalCheck5 is an assayed control for usein calibration verification andfor use in verification of theassay range established by theElecys HCG+β reagent on theindicated Elecys and cobas eimmunoassay analyzers</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Guidance for Industry and FDA Staff – Assayed and Unassayed Quality Control Material

# L. Test Principle:

Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Not applicable

b. Linearity/assay reportable range: Not applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability and value assignment

Elecys HCG STAT CalCheck5 is standardized using internally produced master calibrators which are traceable to the $4 ^ { \mathrm { t h } }$ International Standard for HCG (NIBSC) 75/589.

Each of the five CalCheck levels is value assigned using four Elecys 2010/cobas e411 and e601 analyzers. Each sample is tested in duplicate. The target value of each CalCheck is the median of the observed values.

The labeling states that laboratories should establish appropriate acceptance criteria when using the CalCheck for its intended use.

Stability

The Elecys HCG STAT CalCheck 5 formulation is identical to the Elecys $\mathrm { H C G + \beta }$ CalCheck 5, the stability studies presented and cleared in the $\mathrm { H C G + \beta }$ CalCheck 5 submission, k092168, apply. The Elecys HCG STAT CalCheck 5 is stable until the expiration date printed on the vial when stored unopened at $2 { - } 8 \mathrm { { } ^ { \circ } C }$ . The reconstituted vials are stable for four hours at $2 0 { - } 2 5 ^ { \circ } \mathrm { C }$ .

d. Detection limit: Not applicable   
e. Analytical specificity: Not applicable   
f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: The expected values are provided in the labeling for each specific lot.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.